Viewing Study NCT00564512


Ignite Creation Date: 2025-12-26 @ 10:17 PM
Ignite Modification Date: 2025-12-30 @ 6:25 AM
Study NCT ID: NCT00564512
Status: COMPLETED
Last Update Posted: 2013-07-25
First Post: 2007-11-27
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Fludarabine, Cyclophosphamide, and Rituximab or Alemtuzumab in Treating CLL2007 CLL 2007 FMP
Sponsor: French Innovative Leukemia Organisation
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module